Safety and Immunogenicity Study of GX-70 in TB Patient

NCT03159975 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unconfirmed research expenses

Conditions

Pulmonary Tuberculoses
High Risk Factors for Relapse
Treatment Failure

Interventions

DRUG: GX-70 by electroporation
DRUG: GX-70 by electroporation
DRUG: GX-70 by electroporation

Sponsor

Yonsei University